Literature DB >> 16309826

Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.

Shun-Yao Ko1, Shu-Chun Lin, Yong-Kie Wong, Chung-Ji Liu, Kuo-Wei Chang, Tsung-Yun Liu.   

Abstract

The A disintergin and metalloprotease (ADAM) superfamilies play important roles in angiogenesis, development, and tumorigenesis. Amyloid precursor protein (APP) is an important protein related to Alzheimer's disease. Recent research shows that ADAM10 alpha-secretase activity can release the secreted form of APP. We have previously demonstrated an increase of APP expression in oral squamous cell carcinoma (OSCC) and related OSCC cell lines. The present study characterizes ADAM10 expression in the neoplastic process of OSCC. RT-PCR analysis revealed a two-fold increase in APP mRNA expression in 50% of OSCC (n=50) relative to corresponding non-malignant matched tissues (NMMT). This increase in mRNA expression occurred at the preneoplastic stage. A significant correlation between mRNA expression of ADAM10 and APP in OSCC was noted. A non-buccal subset of OSCC correlated with an increase of mRNA expression of both ADAM10 and APP. The increase of ADAM10 protein expression in the majority of OSCC tissues and cell lines studies was confirmed by Western blot analysis. Additionally, an increase of ADAM10 immunoreactivity in OSCC relative to NMMT was noted. An antisense oligonucleotide against ADAM10 reduced ADAM10 expression as well as growth in an OSCC cell line. However, this treatment did not reduce the secreted form APP. This study suggests that ADAM10 expression plays a role in the carcinogenesis of OSCC and proliferation of OSCC cells, independent of APP processing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309826     DOI: 10.1016/j.canlet.2005.10.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  29 in total

1.  Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region.

Authors:  Sven Lammich; Dominik Buell; Sonja Zilow; Ann-Katrin Ludwig; Brigitte Nuscher; Stefan F Lichtenthaler; Claudia Prinzen; Falk Fahrenholz; Christian Haass
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

2.  The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer.

Authors:  Sercan Ergün; Mustafa Ulasli; Yusuf Ziya Igci; Mehri Igci; Sevil Kırkbes; Ersin Borazan; Ahmet Balik; Önder Yumrutaş; Celalettin Camci; Ecir Ali Cakmak; Ahmet Arslan; Serdar Oztuzcu
Journal:  Mol Biol Rep       Date:  2014-10-16       Impact factor: 2.316

Review 3.  Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer.

Authors:  Ranee Mehra; Ilya G Serebriiskii; Roland L Dunbrack; Matthew K Robinson; Barbara Burtness; Erica A Golemis
Journal:  Drug Resist Updat       Date:  2011-09-14       Impact factor: 18.500

4.  RNAi-mediated ADAM9 gene silencing inhibits metastasis of adenoid cystic carcinoma cells.

Authors:  Qin Xu; Xiuming Liu; Yili Cai; Youcheng Yu; Wantao Chen
Journal:  Tumour Biol       Date:  2010-04-27

5.  Expression of a-disintegrin and metalloproteinase 10 correlates with grade of malignancy in human glioma.

Authors:  Min Qu; B O Qiu; Wende Xiong; Dong Chen; Anhua Wu
Journal:  Oncol Lett       Date:  2015-02-27       Impact factor: 2.967

6.  Clinical significance of ADAM10 expression in laryngeal carcinoma.

Authors:  Bo You; Miao Gu; Xiaolei Cao; Xingyu Li; Si Shi; Ying Shan; Yiwen You
Journal:  Oncol Lett       Date:  2016-12-28       Impact factor: 2.967

7.  ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells.

Authors:  Lin Fu; Nan Liu; Yong Han; Chengyao Xie; Qingchang Li; Enhua Wang
Journal:  Tumour Biol       Date:  2014-06-18

8.  Expression of ADAM10, Fas, FasL and Soluble FasL in Patients with Oral Squamous Cell Carcinoma (OSCC) and their Association with Clinical-Pathological Parameters.

Authors:  José Sergio Zepeda-Nuño; Celia Guerrero-Velázquez; Susana Del Toro-Arreola; Natali Vega-Magaña; Julián Ángeles-Sánchez; Jesse Haramati; Ana L Pereira-Suárez; Miriam R Bueno-Topete
Journal:  Pathol Oncol Res       Date:  2016-09-14       Impact factor: 3.201

9.  Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9.

Authors:  Claus-Werner Franzke; Leena Bruckner-Tuderman; Carl P Blobel
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

10.  Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference.

Authors:  Qin Xu; Xiuming Liu; Wantao Chen; Zhiyuan Zhang
Journal:  J Transl Med       Date:  2010-12-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.